The bifunctional leukotriene A 4 hydrolase catalyzes the final step in the biosynthesis of the proinflammatory leukotriene B 4 . During exposure to the substrate leukotriene A 4 , a labile allylic epoxide, the enzyme is gradually inactivated as a consequence of the covalent binding of leukotriene A 4 to the active site. This phenomenon, commonly referred to as suicide inactivation, has previously been rationalized as a mechanismbased process in which the enzyme converts the substrate to a highly reactive intermediate within an activated enzyme-substrate complex that partitions between covalent bond formation (inactivation) and catalysis. To further explore the molecular mechanism of the self-inactivation of leukotriene A 4 hydrolase by leukotriene A 4 , we prepared and analyzed mutated forms of the enzyme that were either catalytically incompetent or fully active but resistant toward substrate-mediated inactivation. These mutants were treated with leukotriene A 4 and leukotriene A 4 methyl and ethyl esters and subjected to differential peptide mapping and enzyme activity determinations, which showed that inactivation and/or covalent modification can be completely dissociated from catalysis. Our results, together with recent findings described in the literature, argue against a mechanism-based model for suicide inactivation. We conclude that the collected data on the substrate-mediated inactivation of leukotriene A 4 hydrolase best conforms to an affinity-labeling mechanism.
Leukotriene (LT)
1 -A 4 hydrolase (EC. 3.3.2.6.) is a bifunctional zinc metalloenzyme that converts LTA 4 into the proinflammatory substance LTB 4 , a reaction referred to as the epoxide hydrolase activity (1) . In addition, the enzyme possesses an aminopeptidase activity toward a variety of substrates including synthetic chromogenic amides (2) , opioid peptides (3), and arginyl tripeptides (4) . However, the endogenous substrate and the physiological significance of the peptidase activity are still not known.
During catalysis, LTA 4 hydrolase converts LTA 4 stereospecifically to LTB 4 , but a fraction of the substrate will covalently bind to the active site of the enzyme, causing irreversible inactivation of both enzyme activities (5, 6) . This process, usually referred to as suicide inactivation, has been proposed to be rate-limiting in cellular LTB 4 biosynthesis and may therefore be an important mechanism for the overall regulation of this biosynthetic pathway in vivo (7) . Using differential Lys-specific peptide mapping, we have recently identified a heneicosapeptide, denoted K21, encompassing the amino acid residues 365-385 of human LTA 4 hydrolase, which is involved in the binding of LTA 4 and LTA 4 methyl and ethyl ester to the native enzyme. In experiments using LTA 4 ethyl ester, it was possible to identify Tyr-378 as the residue that is involved in the binding of the lipid (8) . In a recent study using site-directed mutagenesis, we could show that a conservative replacement at position 378 increased the turnover for epoxide hydrolysis and rendered the enzyme virtually resistant to suicide inactivation with LTA 4 (9) . Thus, the function of Tyr-378 was not primarily catalytic since (Y378F/Q)LTA 4 hydrolase displayed both enzyme activities. However, the hydrolysis of LTA 4 catalyzed by the mutated enzymes was affected, leading to a mixture of LTB 4 and 5S,12R-dihydroxy-6,10-trans-8,14-cis-eicosatetraenoic acid in a ratio of 1:0.2 for Y378F and 1:0.3 for Y378Q-LTA 4 hydrolase, suggesting that the transition state complexes formed with the mutated enzymes are less well defined as compared with that of the wild type enzyme (10) .
It has been proposed that the substrate-mediated inactivation of LTA 4 hydrolase by LTA 4 is a mechanism-based process (Fig. 1A) , which would imply that the inactivation (i.e. covalent modification) is dependent on turnover and vice versa (5, 6) . In order to test this hypothesis, we investigated the interaction of the catalytically incompetent E318A-LTA 4 hydrolase with LTA 4 and LTA 4 methyl and ethyl ester. In addition, we investigated the mutated enzymes Y378F and Y378Q-LTA 4 hydrolase that are resistant toward substrate-mediated inactivation. Our results indicate that LTA 4 is an affinity label rather than a mechanism-based inhibitor that modifies and blocks the active site by virtue of its binding specificity and inherent chemical reactivity.
EXPERIMENTAL PROCEDURES
Materials-LTA 4 methyl ester was from Biomol, and LTA 4 ethyl ester was from Merck-Frosst Laboratories, Pointe Claire, Quebec, Canada. Alanine-4-nitroanilide, iodoacetic acid sodium salt, and dithiothreitol were from Sigma. LTA 4 ethyl ester was saponified in tetrahydrofuran with 1 M LiOH (6% v/v) for 48 h at 4°C. T7 sequencing kit, restriction endonucleases, T4 DNA ligase, and PD-10 columns were purchased from Amersham Pharmacia Biotech. Nickel nitrilotriacetic acid resin was from Qiagen. Oligonucleotides were synthesized by Scandinavian gene synthesis. Lys-C protease (150 units/mg, Boehringer Mannheim) was dissolved in 1 mM HCl and stored up to 4 weeks at Ϫ20°C.
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‡ 1 The abbreviations used are: LT, leukotriene; LTA 4 , 5S-trans-5,6-oxido-7,9-trans-11,14-cis-eicosatetraenoic acid; LTB 4 , 5S,12R-dihydroxy-6,14-cis-8,10-trans-eicosatetraenoic acid; HPLC, high performance liquid chromatography. mutagenesis on human LTA 4 hydrolase cDNA as described previously (9) . The mutated cDNAs were cloned into the Escherichia coli expression vector pT3-MB4, which generates a His 6 -tagged fusion protein. E318A-LTA 4 hydrolase was previously constructed by oligonucleotidedirected mutagenesis on single-stranded DNA, as described (11) . A BglII/AflII fragment containing the mutated codon was excised from the cDNA and ligated into the expression vector pT3-MB4, previously opened with the same restriction enzymes. The integrity of the final expression construct was verified by DNA sequencing using the dideoxy chain termination method (12) .
Purification of Recombinant LTA 4 Hydrolase-Mutated proteins were expressed in E. coli (JM101) and purified to apparent homogeneity by affinity chromatography on a nickel nitrilotriacetic acid resin followed by hydroxyapatite chromatography, as described (9) .
Enzyme Assays-The epoxide hydrolase activity was determined from incubations of 2 g of LTA 4 hydrolase in 200 l of 50 mM Tris-Cl, pH 8, with 1 l of the substrate LTA 4 (2.4 -2.8 nmol/l) at room temperature. The reaction was stopped after 15 s by the addition of 2 volumes of methanol, and prostaglandin B 1 was added as an internal standard. The samples were acidified to pH 3 with 0.1 M HCl followed by solid phase extraction on Chromabond C 18 columns (Waters). The formation of LTB 4 was analyzed by reverse phase HPLC, and the quantitations were made from area integration based on a standard curve obtained from analysis of known amounts of prostaglandin B 1 and LTB 4 (13) .
The aminopeptidase activity was determined spectrophotometrically in 50 mM Tris-Cl, pH 7.5, containing 100 mM NaCl and 38 g/ml bovine serum albumin with 1 mM alanine-4-nitroanilide as substrate. The reactions were performed in the wells of a microtiter plate with 2 g of purified enzyme, and product formation was measured as an increase in the absorbance at 405 nm, using a multiscan spectrophotometer. Spontaneous hydrolysis of the substrate was corrected for by subtracting the absorbance of control incubations without enzyme (13) .
Inactivation Experiments and Peptide Mapping-Wild type and mutated LTA 4 hydrolase (2 ml, 100 g/ml in 50 mM Tris-Cl, pH 8) was incubated five times with 14 M LTA 4 , LTA 4 methyl ester, or LTA 4 ethyl ester for 30 min at room temperature (final concentration 70 M). A portion of the reaction mixture (100 l) was then gel-filtered on a PD-10 column, and the eluted protein was analyzed for residual epoxide hydrolase and peptidase activity. The remaining enzyme was subjected to Lys-C digestion and differential peptide mapping by reverse phase HPLC as described (8) . Peptides K21 and Y378F-K21 were identified by amino acid sequence analysis (8, 9) . The presence (or loss) of K21 or (Y378F/Q)K21 in samples of enzyme treated with LTA 4 or LTA 4 methyl or ethyl ester was calculated from the peak height at 280 nm in peptide maps as described (8) . Values were normalized with respect to neighboring peaks to compensate for variations in recovery and were expressed in percent of the corresponding peak height obtained with untreated enzyme.
For separate tests of enzyme inactivation, small-scale (100 l) incubations of LTA 4 hydrolase (100 g/ml in 50 mM Tris-Cl, pH 8) with 3 ϫ 2.6 M LTA 4 (final concentration 78 M) were performed followed by gel filtration (PD-10) and activity determinations. 4 Hydrolase-Glutamic acid at position 318 is the third zinc binding ligand in the active site of LTA 4 hydrolase (1). Accordingly, E318A-LTA 4 hydrolase has been shown to lack the catalytic zinc atom and is therefore virtually devoid of epoxide hydrolase and aminopeptidase activity (11, 14) . We utilized this mutant to investigate if a catalytically incompetent enzyme could be modified by the substrate LTA 4 or its ester derivatives. To this end, E318A-LTA 4 hydrolase (200 g in 2 ml of Tris-Cl, pH 8, 10 mM EDTA) was exposed to five consecutive additions of 14 M LTA 4 at 30-min intervals and processed as described above. Peptide maps of untreated E318A-LTA 4 hydrolase and E318A exposed to LTA 4 were identical except for peptide K21, previously identified as the peptide to which LTA 4 binds during suicide inactivation (8, 9) . Thus, in peptide maps of enzyme treated with LTA 4 , K21 was reduced to approximately 25% of the untreated control (see Fig. 2 ; Table I ). In addition, novel peaks appeared in the more lipophilic region of the chromatogram, in line with the notion that modification of the active-site peptide K21 had occurred (data not shown). Interestingly, for the catalytically active wild type enzyme, the modification as well as the corresponding inactivation by LTA 4 did not exceed 50% of the untreated control (see Fig. 3 ) (8) .
RESULTS

Covalent Modification of E318A-LTA
Under the same conditions, LTA 4 methyl or ethyl ester reacted with E318A-LTA 4 hydrolase in a similar way, leading to a specific modification of peptide K21 as judged by its disappearance (remaining peptide 18 and 10% of the control, respectively) in the corresponding peptide maps (Table I) . Notably, the extent of peptide modification when E318A-LTA 4 hydrolase was treated with LTA 4 methyl and ethyl ester was comparable to the corresponding modification of peptide K21 using wild type enzyme (23 and 14% of the control, respectively). In all experiments with peptide mapping of E318A-LTA 4 hydrolase, the low recovery of modified peptides prevented their isolation and amino acid sequencing. Hence, the site of attachment between lipid and protein could not be determined.
Treatment of (Y378F/Q)LTA 4 Hydrolase with LTA 4 Methyl and Ethyl Ester-The three allylic epoxides LTA 4 , LTA 4 methyl ester, and LTA 4 ethyl ester are all effective inhibitors of LTA 4 hydrolase, but the latter two compounds do not generate detectable amounts of products and are therefore generally not regarded as substrates for LTA 4 hydrolase. Nevertheless, based on kinetic data, inactivation of the enzyme by LTA 4 methyl ester has been interpreted as a mechanism-based process, albeit with negligible turnover (6) . With this interpretation, the rate of inactivation would by far exceed the rate of product formation (cf. Fig. 1A ). Since Y378F-LTA 4 hydrolase is resistant to suicide inactivation and exhibits an increased turnover of LTA 4 (9) , this enzyme could potentially be more efficient in converting the ester derivatives of LTA 4 into product. However, in our activity assays (1 g of enzyme in 100 l, 50 mM Tris-Cl, pH 8, incubated with 2.6 nmol of LTA 4 methyl or ethyl ester) Y378F-LTA 4 hydrolase failed to generate any detectable amounts of the corresponding esters of LTB 4 . Moreover, when the amounts of enzyme and LTA 4 esters were increased to 20 g (28 nmol) and 76 nmol, respectively, and the time of incubation was extended to 20 min, no formation of enzymatic products could be detected. Hence, under these seemingly optimized conditions, we could not detect any enzymatic turnover of the ester derivatives of LTA 4 , suggesting that these compounds are neither substrates nor mechanism-based inhibitors of LTA 4 hydrolase.
To investigate if (Y378F/Q)LTA 4 hydrolase were resistant also to inactivation with LTA 4 methyl and ethyl ester, the effects of treatment with these leukotriene epoxides were compared with the inactivation pattern observed for wild type enzyme (Table II) . The two mutants S379A-and S380A-LTA 4 hydrolase, which are not protected from suicide inactivation (9), were prepared and treated under the same conditions to serve as controls. Surprisingly, partial inactivation of the epoxide hydrolase activities of Y378F-and Y378Q-LTA 4 hydrolase was observed although not to the same extent as for the wild type enzyme and the two control mutants S379A-and S380A-LTA 4 hydrolase (Table II) . Thus, for Y378F-and Y378Q-LTA 4 hydrolase, inactivation of the epoxide hydrolase activity with LTA 4 methyl ester was significant, yielding 52 and 44% inhibition, respectively. The corresponding effect of LTA 4 ethyl ester was less pronounced, with 40 and 16% inhibition for Y378F and Y378Q, respectively. Under the same incubation conditions, the control enzymes lost about 70 and 80% of the initial epoxide hydrolase activity by treatment with LTA 4 methyl and ethyl ester, respectively. Typically, treatment of wild type and S379A-and S380A-LTA 4 hydrolase with LTA 4 or LTA 4 methyl or ethyl ester results in an equal and parallel loss of both enzyme activities (9) (Table II) . However, the peptidase activities of Y378F-and Y378Q-LTA 4 hydrolase were not inactivated but rather stimulated by treatment with the ester compounds (except for LTA 4 ethyl ester, which slightly inhibited the peptidase activity of Y378F-LTA 4 hydrolase), indicating that these mutants become modified at a different position within the active site (see below).
Peptide Mapping of Inactivated Enzymes-To determine the effects of mutation of Tyr-378 on covalent modification of LTA 4 hydrolase by LTA 4 methyl and ethyl ester, large scale inactivation experiments (200 g of enzyme) with subsequent proteolytic cleavage and HPLC peptide mapping were performed. The modification of the active-site peptide K21 or Y378F-K21 was determined from the reduction of the corresponding peptide peak in the peptide maps. Although Y378F-LTA 4 hydrolase was neither inactivated nor modified by LTA 4 (9) (Fig. 3) , LTA 4 methyl and ethyl ester did inactivate the epoxide hydrolase activity and modify Y378F-LTA 4 hydrolase, although not to the same extent as observed for the wild type enzyme (Table  I and II; Fig. 3) . Furthermore, the inactivation of the epoxide hydrolase activity of Y378F-LTA 4 hydrolase appeared to be reflected by a proportional loss of peptide Y378F-K21 (Table I) , indicating a modification within the same peptide segment as in the unmutated enzyme but yet at a different position (see above). Novel peaks, which eluted late in the peptide maps, appeared in analyses of enzyme that had been inactivated with ester derivatives of LTA 4 (data not shown). These peaks may be lipid-protein adducts that elute late as compared with the corresponding free peptides due to their increased hydrophobicity. However, because of the low recovery, those peptides could not be isolated and sequenced. DISCUSSION LTA 4 , the key precursor of the biologically active leukotrienes, is an unusual example of an endogenous compound that is both a natural substrate and an irreversible inactivator of a target enzyme, i.e. LTA 4 hydrolase. Results obtained by several experimental approaches have indicated that this inactivation of LTA 4 hydrolase satisfies criteria of a mechanismbased process (6) (Fig. 1A) . Thus, after treatment of native and recombinant human LTA 4 hydrolase with LTA 4 or LTA 4 methyl ester, the epoxide hydrolase and peptidase activities are lost simultaneously and irreversibly in a time-dependent, saturable process that is of pseudo first-order kinetics. There is a direct relationship between catalysis and inactivation with equivalent pH dependence for both processes. Active-site specificity has been demonstrated by protection with competitive inhibitors (6, 8, 15) , and mass spectrometric analysis has revealed that suicide inactivation occurs predominantly in a 1:1 stoichiometry between lipid and protein, with only little modification of secondary sites (6) . From these data, substratemediated inactivation of LTA 4 hydrolase has been classified as a mechanism-based process. However, all these criteria are also consistent with an affinity-labeling mechanism (Fig. 1B) .
Mechanism-based Inhibitors Versus Affinity Labels-A mechanism-based inhibitor is an unreactive molecule that is activated by the catalytic machinery of an enzyme into a reactive product which in turn will covalently modify an active-site residue. Typically, a mechanism-based inhibitor is a synthetically prepared substrate analogue that has been designed to covalently bind a catalytic acid-base of the transition state after its enzymatic transformation into a reactive species (16, FIG. 1. Schematic representation of mechanism-based inactivation (A) versus affinity-labeling (B) . Scheme A depicts mechanism-based inactivation of LTA 4 hydrolase. LTA 4 forms an enzymesubstrate complex and, within this complex, is enzymatically converted to a highly reactive species, LT * . LT * may either be subject to a second enzymatic transformation to form LTB 4 or may covalently bind to an active-site residue. Scheme B exemplifies an affinity-labeling mechanism. The electrophilic LTA 4 is noncovalently bound to the active site, from where it captures a proximate residue without any catalytic assistance by the enzyme. This process may be suppressed to a certain extent by the enzymatic conversion of the reactive LTA 4 to LTB 4 . The partition ratio (turnover/inactivation) is determined by the rate constants k 3 and k 4 (5) in scheme A or the rate constants k 2 and k 3 in scheme B, respectively. 17). Since the mechanism-based inhibitor requires the catalytic apparatus for its action, this type of compound is ideal for the development of highly specific enzyme inhibitors. In contrast, an affinity label is a molecule that is chemically reactive in itself and therefore does not need enzymatic processing to become destructive. This type of inhibitor, which resembles the substrate, will also modify the active site because of its binding specificity. On the other hand, an affinity label could potentially react with any protein to which it binds with sufficient strength. Thus, the distinction between a mechanism-based inhibitor and an affinity label has important pharmacological and biological implications, and the two modes of inactivation can be schematically illustrated as in Fig. 1 .
Apparently, a critical point in deciding which mechanism best describes the substrate-mediated inactivation of LTA 4 hydrolase will be to determine whether or not the enzyme machinery is required for generation of the reactive inactivating molecule. One possible species could be a carbocation, which is formed during nonenzymatic hydrolysis of LTA 4 and which also seems to be an intermediate in the conversion of LTA 4 into LTB 4 (18) .
The Catalytically Inactive Mutant E318A-LTA 4 Hydrolase Is Covalently Modified by LTA 4 -Mutagenetic replacement of any of the three zinc binding ligands in LTA 4 hydrolase including Glu-318 leads to the combined loss of zinc and enzyme activities (11) . Thus, the mutant E318A-LTA 4 hydrolase was selected to study the effects of leukotriene epoxides on an enzyme lacking a key element of catalysis, the fundamental basis for a mechanism-based process. Exposure of E318A-LTA 4 hydrolase to LTA 4 or LTA 4 methyl or ethyl ester resulted in covalent modification of peptide K21 to the same extent as for wild type enzyme ( Figs. 2 and 3 ; Table I ). This finding is very difficult to rationalize within the concept of a mechanism-based process in which catalytic activation of the substrate is necessary and precedes covalent modification and inactivation. In fact, the degree of modification was even higher in the absence of catalysis (cf. Figs. 2 and 3) . Given an affinity-labeling mechanism, the latter observation can be explained by the enzymatic capacity of LTA 4 hydrolase to convert the reactive substrate to the stable end product LTB 4 , thereby suppressing the destructive side reaction with the protein.
Covalent Modification of a Nonessential Residue at the Active Site of LTA 4 Hydrolase-Tyr-378 has been identified as a major site to which LTA 4 binds during suicide inactivation (8) . Exchange of Tyr-378 for a Phe or Gln rendered the enzyme virtually resistant to suicide inactivation and, in addition, Y378F-LTA 4 hydrolase exhibited an increased k cat for LTA 4 (9) . Hence, turnover was completely dissociated from inactivation, which shows that Tyr-378 is not critical for catalysis. Modification of a nonessential active-site residue would be consistent with an affinity-labeling mechanism (17) in which LTA 4 may simply become captured by a proximate nucleophilic residue at the active site, namely Tyr-378.
Leukotriene Epoxides Bind to More Than One Site within Peptide K21-Although Y378F-and Y378Q-LTA 4 hydrolases were not susceptible to covalent modification/inactivation by LTA 4 (9), these two mutants were only partially protected against inactivation by LTA 4 methyl and ethyl ester (Table II, Fig. 3 ), none of which was turned over into a detectable product. Thus, after treatment with esterified LTA 4 , the epoxide hydrolase activities were reduced, albeit not to the same extent as for wild type enzyme, whereas the peptidase activities were almost unaffected or, in the case of Y378Q-LTA 4 hydrolase, even stimulated (Table II) . Furthermore, experiments with peptide mapping of Y378F-LTA 4 hydrolase treated with the ester derivatives of LTA 4 showed that the modification had occurred within peptide K21, which represents at least a part of the substrate binding pocket (Fig. 3) . Inasmuch as suicide inactivation of wild type LTA 4 hydrolase typically affects both activities to the same extent, the selective inhibition of the epoxide hydrolase activity, without concomitant loss of the peptidase activity, lends further support to the conclusion that the lipid/protein adduct has been formed at a different site in the active center. Hence, although Tyr-378 appears to be best positioned for modification by LTA 4 , other nucleophilic residues along K21 may also react with the epoxide, at least in the case of esterified LTA 4 . Moreover, the unproductive binding of LTA 4 methyl and ethyl ester to the active site (no detectable formation of LTB 4 esters) and the tendency to form several alternative covalent bonds would also be consistent with an affinity-labeling mechanism.
Molecular Mechanism of Substrate-mediated Inactivation of LTA 4 Hydrolase-Based on primarily kinetic data, suicide inactivation of LTA 4 hydrolase has been interpreted as a mechanism-based process (5, 6) . However, this model is difficult to reconcile with certain properties of LTA 4 . For instance, the molecule LTA 4 , its ester derivatives, and structurally related allylic epoxides are all chemically labile compounds that react indiscriminately with all nucleophiles available. In fact, the half-life of LTA 4 is less than 10 s in aqueous solutions (25°C, phosphate buffer, pH 7.4) (19) . Hence, an additional step of substrate activation does not seem to be required for covalent bond formation/inactivation. The importance of the chemical reactivity of the allylic epoxide in LTA 4 for suicide inactivation is also underscored by the fact that other structurally dissimilar allylic epoxides (20) also inactivate LTA 4 hydrolase, whereas non-allylic epoxides do not (Fig. 4) .
As one would expect from an affinity label, LTA 4 has been shown to inactivate enzymes other than LTA 4 hydrolase, i.e. 5-lipoxygenase (21) and platelet-type 12-lipoxygenase (22) , for which LTA 4 is a product or a substrate, respectively. Recently, it was also shown that leukocyte-type 12 lipoxygenase converted 15S-hydroperoxy-5,8,11,13-eicosatetraenoic acid to 14,15-LTA 4 , which bound covalently to the enzyme, leading to irreversible inactivation (23) . The catalytic apparatus of a lipoxygenase would be expected to be greatly different from that of an epoxide hydrolase. However, binding specificity of LTA 4 to lipoxygenases is reasonable, given the structural similarity between LTA 4 and arachidonic acid, the natural substrate of these lipoxygenases. Accordingly, the K i of LTA 4 versus 5-lipoxygenase was calculated to ϳ2 M, and the K m versus 12-lipoxygenase was determined to ϳ8 M. Hence, the affinity between LTA 4 and the lipoxygenases appears to be of the same, or even higher, strength as that reported for LTA 4 hydrolase (K m in the range of 5-30 M).
From analysis of mutated forms of LTA 4 hydrolase Y378F/Q and E318A, we have now been able to thoroughly investigate the molecular interactions between enzyme and substrate that occur during suicide inactivation of LTA 4 hydrolase. Thus, in contrast to what one would expect from a mechanism-based process, we have shown that covalent modification by LTA 4 occurred at the active site of a catalytically incompetent enzyme and that a minimal change of an active-site residue generated an enzyme with increased catalytic efficiency and resistance to suicide inactivation.
Taken together, we think that this large body of data is best explained by LTA 4 acting as an affinity label. In this model, LTA 4 is the natural substrate of the enzyme and at the same time, by virtue of its chemical reactivity, an efficient affinity label. After initial binding of LTA 4 to the active site, the hydroxyl group of Tyr-378 may attack the reactive allylic epoxide or a spontaneously formed carbocation thereof to cause covalent modification/enzyme inactivation. Moreover, this mechanistic model agrees well with the current knowledge about LTA 4 hydrolase, the kinetics of catalysis and inactivation, the chemistry of LTA 4 , and, most important, the properties of our mutated enzymes.
